Waylink Life Science Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 10-12-2024
- Paid Up Capital ₹ 2.06 M
as on 10-12-2024
- Company Age 29 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 4.00 M
as on 10-12-2024
- Revenue 664.37%
(FY 2022)
- Profit 4321.92%
(FY 2022)
- Ebitda -287.43%
(FY 2022)
- Net Worth 0.91%
(FY 2022)
- Total Assets -10.03%
(FY 2022)
About Waylink Life Science
The Corporate was formerly known as Kingsway International Pvt Ltd. The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 2.06 M.
The company has closed loans amounting to ₹4.00 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Arun Kumar, Vinita Baid, and Aakash Baid serve as directors at the Company.
- CIN/LLPIN
U51909WB1995PTC073551
- Company No.
073551
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Aug 1995
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Howrah, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Waylink Life Science?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arun Kumar  | Director | 17-Aug-1995 | Current |
| Vinita Baid | Director | 15-Feb-2007 | Current |
| Aakash Baid | Director | 06-Jul-2024 | Current |
Financial Performance of Waylink Life Science.
Waylink International Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 664.37% increase. The company also saw a substantial improvement in profitability, with a 4321.92% increase in profit. The company's net worth moved up by a moderate rise of 0.91%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Waylink Life Science?
Unlock access to Waylink Life Science's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Webiroid Technology & Consultancy Services Private LimitedActive 6 years 1 monthAakash Baid is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Icici Bank Limited Creation Date: 29 Sep 2011 | ₹4.00 M | Satisfied |
How Many Employees Work at Waylink Life Science?
Unlock and access historical data on people associated with Waylink Life Science, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Waylink Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Waylink Life Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
